Zhibao Technology (ZBAO) H1 2024 earnings summary

Executive summary

• Total revenues for H1 2024 decreased by 8% year-over-year to RMB 84.3 million ($11.9 million), primarily due to reduced renewals and the abrupt closure of a reinsurance partner in high-end medical insurance.

• Net loss was RMB 8.5 million ($1.2 million), compared to net income of RMB 8.9 million in the prior year period.

• Significant investments were made in sales, marketing (up 66%), and R&D (up 82%) to drive future growth.

• The company completed its IPO in April 2024, raising $6 million, and issued additional shares in May 2024 for $95,060.

Financial highlights

• Insurance brokerage service fees fell to RMB 71.4 million, and MGU service fees to RMB 13.2 million, both down year-over-year.

• Cost of revenues decreased 8% to RMB 54.2 million, maintaining a cost ratio of about 64%.

• Non-GAAP adjusted net loss was RMB 6.3 million ($0.9 million).

• Basic and diluted net loss per share was RMB 0.28 ($0.04); adjusted net loss per share was RMB 0.20 ($0.03).

• Cash and cash equivalents as of December 31, 2023, were RMB 5.5 million ($0.8 million).

Outlook and guidance

• Management expects strong full-year revenue and profit growth for fiscal 2024.

• Strategic focus on organic growth, M&A, and operational efficiency through the "Project Amoeba" reorganization.

• Optimism about the embedded insurance brokerage industry and continued expansion of client base.